Thomas T. Chou - Concepedia

Author

Thomas T. Chou

Also Known As

T. Chou, T. T. CHOU, T. T. Chou, Thomas Chou, Thomas T Chou, Thomas T. -t. Chou, Thomas T. Chou, Thomas T. T. Chou, Thomas T.-t. Chou

Publications

9.1K

Citations

H-Index

Concepts

All Affiliations

University of Pennsylvania Pfizer (United States)Children's Hospital of Philadelphia University of Groningen University Medical Center Groningen

About

Thomas T. Chou is an author at University of Pennsylvania specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	2.4K
2	Cell Biology	3	3	263
3	Biochemistry	2	2	92
4	Health Sciences	1	1	60
5	Natural Sciences	1	1	32

Thomas T. Chou

Publications

Citations

H-Index

Page 1

	Year	Citations
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis Manuela Neumann, Deepak M. Sampathu, Linda K. Kwong, Science	2006	6.5K
Neuregulin 1 and Susceptibility to Schizophrenia Hreinn Stefánsson, Hannes Pétursson, Engilbert Sigurðsson, The American Journal of Human Genetics PsychiatryPsychotic DisorderPsychiatric GeneticsNeuregulin 1Schizophrenia	2002	1.7K
Pathological Heterogeneity of Frontotemporal Lobar Degeneration with Ubiquitin-Positive Inclusions Delineated by Ubiquitin Immunohistochemistry and Novel Monoclonal Antibodies Deepak M. Sampathu, Manuela Neumann, Linda K. Kwong, American Journal Of Pathology ImmunohematologyImmunodeficienciesImmunologyPathological HeterogeneityPathology	2006	321
Nerve Growth Factor Induces Apoptosis in Human Medulloblastoma Cell Lines that Express TrkA Receptors Yoshihiro Muragaki, Thomas T. Chou, David R. Kaplan, Journal of Neuroscience ApoptosisImmunologyCell DeathPathologyHuman Medulloblastoma Cell	1997	117
Biological stability of RNA isolated from RNAlater-treated brain tumor and neuroblastoma xenografts Michael A. Grotzer, Ratnakar Patti, Birgit Geoerger, Medical and Pediatric Oncology	2000	95
Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells Angelika Eggert, Naohiko Ikegaki, Xing-ge Liu, Oncogene Lineage PlasticitySignal TransductionSignaling PathwayCell RegulationCell Interaction	2000	89
Benzyloxazolidine-2,4-diones as potent hypoglycemic agents Robert L. Dow, Bruce M. Bechle, Thomas T. Chou, Journal of Medicinal Chemistry Metabolic SyndromeBenzofuran Structural ElementBiochemistryVivo PotencyPhysiology	1991	60
A Novel Apoptotic Pathway Induced by Nerve Growth Factor-mediated TrkA Activation in Medulloblastoma Thomas T. Chou, John Q. Trojanowski, Virginia M.‐Y. Lee Journal of Biological Chemistry Tumor InnervationApoptosisImmunologyPathologyCell Death	2000	57
Identification of Tricyclic Analogs Related to Ellagic Acid as Potent/Selective Tyrosine Protein Kinase Inhibitors Robert L. Dow, Thomas T. Chou, Bruce M. Bechle, Journal of Medicinal Chemistry	1994	45
A Phase 1, Single-center, Double-blind, Placebo-controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Clinical Effects, and Pharmacokinetics–Pharmacodynamics of Intravenous Cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a Single Ascending Bolus Dose Michel Struys, Beatrijs I. Valk, Douglas J. Eleveld, Anesthesiology	2017	37

Page 1